Back
ADMA Biologics Stock Price Chart

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
63
ADMA
ADMA Biologics
Last Price:
$21.64
Seasonality Move:
4.65%
7 Day Trial
ALL ACCESS PASS
$
7

Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ADMA is experiencing slight buying pressure.
ADMA Biologics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.01 | Buy |
20-day SMA: | 19.56 | Buy |
50-day SMA: | 17.8 | Buy |
200-day SMA: | 17.18 | Buy |
8-day EMA: | 19.44 | Buy |
20-day EMA: | 19.13 | Buy |
50-day EMA: | 18.42 | Buy |
200-day EMA: | 16.22 | Buy |
ADMA Biologics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.41 | Buy |
Relative Strength Index (14 RSI): | 60.86 | Buy |
Chaikin Money Flow: | 3317938 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.33 - 20.23) | Buy |
Bollinger Bands (100): | (16.44 - 19.86) | Buy |
ADMA Biologics Technical Analysis
Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for ADMA Biologics Stock
Is ADMA Biologics Stock a Buy?
-
ADMA Biologics share price is 20.91 while ADMA 8-day simple moving average is 19.01, which is a Buy signal.
-
The stock price of ADMA is 20.91 while ADMA Biologics 20-day SMA is 19.56, which makes it a Buy.
-
ADMA Biologics 50-day simple moving average is 17.80 while ADMA share price is 20.91, making it a Buy technically.
-
ADMA stock price is 20.91 and ADMA Biologics 200-day simple moving average is 17.18, creating a Buy signal.
ADMA Technical Analysis vs Fundamental Analysis
Buy
63
ADMA Biologics (ADMA)
is a Buy
Is ADMA Biologics a Buy or a Sell?
-
ADMA Biologics stock is rated a BuyThe current ADMA Biologics [ADMA] share price is $20.91. The Score for ADMA is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
ADMA Biologics Stock Info
Market Cap:
5B
Price in USD:
20.91
Share Volume:
6.8M
ADMA Biologics 52-Week Range
52-Week High:
23.64
52-Week Low:
5.91
Buy
63
ADMA Biologics (ADMA)
is a Buy
ADMA Biologics Share Price Forecast
-
What is the ADMA Biologics stock price today?The ADMA Biologics stock price is 20.91 USD today.
-
Will ADMA stock go up or go down?ADMA Biologics> share price is forecast to RISE/FALL based on technical indicators
-
Is ADMA Biologics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ADMA Biologics is not overvalued.
Is ADMA Biologics Stock a Buy?
-
ADMA Biologics share price is 20.91 while ADMA 8-day exponential moving average is 19.44, which is a Buy signal.
-
The stock price of ADMA is 20.91 while ADMA Biologics 20-day EMA is 19.13, which makes it a Buy.
-
ADMA Biologics 50-day exponential moving average is 18.42 while ADMA share price is 20.91, making it a Buy technically.
-
ADMA stock price is 20.91 and ADMA Biologics 200-day simple moving average is 16.22, creating a Buy signal.
Fundamental Analysis of ADMA Biologics
Is ADMA Biologics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.25 per share.
Technical Analysis of ADMA Biologics
Should I short ADMA Biologics stock?
-
ADMA Moving Average Covergence Divergence (MACD) indicator is 0.41, suggesting ADMA Biologics is a Buy
-
ADMA Biologics Relative Strength Index (RSI) is 60.86, which suggest ADMA Biologics is overbought
-
The Bollinger Bands (25) for ADMA Biologics is (18.33 - 20.23), which suggest ADMA Biologics is a Buy
-
The Bollinger Bands (100) for ADMA Biologics is (16.44 - 19.86), which suggest ADMA Biologics is a Buy
* ADMA Biologics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.